Delivery Order SPE2DR25D2206-SPE2DR26F9XP1
Award Date 3/23/26
Potential Completion Date 4/13/26
Potential Value $23K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency issued a $23,100.31 delivery order to AmerisourceBergen Drug Corp on February 25, 2026, for supply of Tibsovo 250 mg tablets (60 count).</p> <p>The order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. Ultimate completion date is March 18, 2026. Pricing is firm fixed price with no set-aside applied.</p>
- The Defense Logistics Agency issued a $46,200.62 delivery order to Amerisourcebergen Drug Corp on March 20, 2026, for TIBSOVO 250 MG tablets (60-count supply), with an ultimate completion date of April 10, 2026. The order is issued under a parent Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which supports global pharmaceutical supply to military healthcare programs. Place of performance is Conshohocken, Pennsylvania. The order is...
- The Defense Logistics Agency issued a $23,100.31 delivery order to Amerisourcebergen Drug Corp on March 18, 2026, for TIBSOVO 250 mg tablets (60-count). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. Place of performance is...
- The Defense Logistics Agency awarded a $21.8K delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Tibsovo (ivosidenib) 250 mg tablets in a quantity of 60 units. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The contract is set to be completed by December 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $21,827.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of TIBSOVO 250 mg on August 7, 2025, with completion scheduled for August 28, 2025. This non-set-aside award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $23,002.73 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of TIBSOVO 250 mg, with a completion date of January 9, 2026. This non-set-aside contract was competitively awarded and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The place of performance is AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $21,827.41 to AmerisourceBergen Drug Corp for TIBSOVO 250 mg tablets (60-count units) on November 6, 2025, with completion scheduled for December 1, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,100.31 to AmerisourceBergen Drug Corp for the supply of TIBSOVO (ivosidenib) 250 mg tablets (60-count packages) on January 12, 2026, with an ultimate completion date of February 3, 2026. This is a firm fixed-price, non-set-aside contract with place of performance in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with...
- <p>The Defense Logistics Agency awarded a $19,482 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561706899 TIBSOVO 250 MG TABLET 60S. The prime contractor will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 25, 2023 in support of DLA programs. Amerisourcebergen will perform under the contract without a designated set aside. No subcontractors or additional context were provided regarding the agency's use of the products.</p>
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) on November 4, 2025, for TIBSOVO 250 mg tablets (60-count supply) with a firm fixed price ceiling value of $21,827.41. The contract is scheduled for completion by November 26, 2025. This is a competitively awarded, non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9XP1Delivery Order
The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 23, 2026, for Tibsovo 250 mg tablets (60-count supply) with a ceiling value of $23,100.31 under firm fixed-price terms. Place of performance is Conshohocken, PA. The ultimate completion date is April 13, 2026. No set-aside was used in this award.
Generated 6/21/26, 10:57 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.1k | 3/22/26 |